GlycoEra
GlycoEra develops biologics to selectively degrade specific circulating proteins that drive autoimmune diseases.
$130M Series B+ ·
Led by Novo Holdings · Source: fundraisingfox.com
Total raised: $179M across 2 sourced rounds
All 2 rounds ↓Signals
About GlycoEra
Its platform designs therapeutics to target disease-causing proteins like autoantibodies. The company aims to improve patient outcomes by enabling earlier intervention in autoimmune conditions.
GlycoEra | 610 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $130M | fundraisingfox.com | ||
| Series A | $49M | bioworld.com |
Timeline
- X account created
- Website created
Founders and team
AF
Amir Faridmoayer FounderDN
Dominique N. Sirena FounderVG
Veronica Gambillara Fonck FounderGK
Ganesh Kaundinya President and CEOGF
Greg Fralish Chief Business OfficerPD
Petra Duda Chief Medical OfficerTG
Tanmoy Ganguly Chief Scientific Officer
Investors
55AM Ventureslead investor
AAgent Capital
BBristol-Myers Squibb
CCatalio
LLifeArc Ventures
- LLimmaTech Biologics
MMP Healthcare Venture Management
NNovo Holdingslead investor
QQatar Investment Authority
RRoche Venture Fundlead investor
SSixty Degree Capital
SSofinnova Partnerslead investor
Companies like GlycoEra
MMerida Biosciences$120M Series A · May 2025
AAtavistik Bio$40M Series B+ · Mar 2026
AAnaveon$120M Series B+ · Dec 2021
AAsher Bio$55M Series B+ · Apr 2024
TTentarixSeries B+ · Sep 2023
LLaigo Bio$19.7M Seed · Mar 2026
Other companies backed by Novo Holdings
OOMass Therapeutics$310M Series B+ · Oct 2026
AAnaCardio$70.97M Series B+ · Sep 2026
BBreye Therapeutics$76.65M Series A · Sep 2026
CClaris Bio$118M Series B+ · Jul 2026
BBactolife$34.9M Series B+ · Jan 2026
SSidera Bio$109.99M Series A · Nov 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/glycoera (get a free API key).